Approved Hospital Formulary
QR Code Add Formweb to your mobile device
Approved Hospital Formulary
Search results for:

abciximab

abciximab
Brand names: Reopro
Form Strength
SOLUTION, INTRAVENOUS 2 mg/mL


Additional Information:

Abciximab (Reopro) was a non-formulary medication as of 2019.  Now, Abciximab is no longer marketed in the US.


Last updated: Aug. 19, 2024







This site is intended for the staff of Legacy Health.
While others may view accessible pages, Legacy Health makes no warranty, express or implied,
as to the use of this information outside of Legacy Health.